Latest filing published 11 Jun 2018 for Arix Bioscience plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Hedley Rawlingson: trading record in brief
All filings by James Hedley Rawlingson on record concern Arix Bioscience plc. Over a trading history stretching from 26 May 2017 to 7 June 2018, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €62k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises.
The record was last updated on 11 June 2018 with an option exercise in Arix Bioscience plc. The most recent open-market purchase was published on 5 June 2017, 3,443 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. The legal deadline for notifying a trade is three business days (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Hedley Rawlingson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 201,492 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-1
- 26,000 shares@ £2.061100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-1Canonical exit: 31 Aug 2017 (T+90)
- 205,062 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-2
3 of 3 declarations